These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26520563)

  • 1. Assessment of Retrograde Coronary Venous Infusion of Mesenchymal Stem Cells Combined with Basic Fibroblast Growth Factor in Canine Myocardial Infarction Using Strain Values Derived from Speckle-Tracking Echocardiography.
    Sun QW; Zhen L; Wang Q; Sun Y; Yang J; Li YJ; Li RJ; Ma N; Li ZA; Wang LY; Nie SP; Yang Y
    Ultrasound Med Biol; 2016 Jan; 42(1):272-81. PubMed ID: 26520563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial Infarction.
    Wang X; Zhen L; Miao H; Sun Q; Yang Y; Que B; Lopes Lao EP; Wu X; Ren H; Shi S; Lau WB; Ma X; Ma C; Nie S
    Theranostics; 2015; 5(9):995-1006. PubMed ID: 26155315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.
    Li SR; Qi XY; Hu FL; Zhang JQ; Wang TH; Dang Y; Meng CL; Liu HL; Li YX; Wu D; Dong J; Xun LY; Gao LH; Jin FC
    Chin Med J (Engl); 2008 Dec; 121(23):2403-9. PubMed ID: 19102957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary infusion of encapsulated glucagon-like peptide-1-eluting mesenchymal stem cells preserves left ventricular function in a porcine model of acute myocardial infarction.
    de Jong R; van Hout GP; Houtgraaf JH; Kazemi K; Wallrapp C; Lewis A; Pasterkamp G; Hoefer IE; Duckers HJ
    Circ Cardiovasc Interv; 2014 Oct; 7(5):673-83. PubMed ID: 25294400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.
    Wang YQ; Wang M; Zhang P; Song JJ; Li YP; Hou SH; Huang CX
    Chin Med J (Engl); 2008 Nov; 121(22):2290-8. PubMed ID: 19080335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic angiogenesis with intramyocardial administration of basic fibroblast growth factor.
    Kawasuji M; Nagamine H; Ikeda M; Sakakibara N; Takemura H; Fujii S; Watanabe Y
    Ann Thorac Surg; 2000 Apr; 69(4):1155-61. PubMed ID: 10800811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of basic fibroblast growth factor on angiogenesis and on the expression of basic fibroblast growth factor and vascular endothelial growth factor in acute infarcted myocardium].
    Liu Y; Sun LJ; Huan Y; Zhao HT; Ge YL; Gao FB
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):54-7. PubMed ID: 14990160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart.
    Tao B; Cui M; Wang C; Ma S; Wu F; Yi F; Qin X; Liu J; Wang H; Wang Z; Ma X; Tian J; Chen Y; Wang J; Cao F
    Theranostics; 2015; 5(2):196-205. PubMed ID: 25553108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoluminescent Mesoporous Silicon Nanoparticles with siCCR2 Improve the Effects of Mesenchymal Stromal Cell Transplantation after Acute Myocardial Infarction.
    Lu W; Xie Z; Tang Y; Bai L; Yao Y; Fu C; Ma G
    Theranostics; 2015; 5(10):1068-82. PubMed ID: 26199646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardium-targeted transplantation of mesenchymal stem cells by diagnostic ultrasound-mediated microbubble destruction improves cardiac function in myocardial infarction of New Zealand rabbits.
    Xu YL; Gao YH; Liu Z; Tan KB; Hua X; Fang ZQ; Wang YL; Wang YJ; Xia HM; Zhuo ZX
    Int J Cardiol; 2010 Jan; 138(2):182-95. PubMed ID: 19383567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.
    Yang J; Zhou W; Zheng W; Ma Y; Lin L; Tang T; Liu J; Yu J; Zhou X; Hu J
    Cardiology; 2007; 107(1):17-29. PubMed ID: 16741354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction.
    Liu C; Fan Y; Zhou L; Zhu HY; Song YC; Hu L; Wang Y; Li QP
    Int J Cardiol; 2015 Jun; 188():22-32. PubMed ID: 25880576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
    Deuse T; Peter C; Fedak PW; Doyle T; Reichenspurner H; Zimmermann WH; Eschenhagen T; Stein W; Wu JC; Robbins RC; Schrepfer S
    Circulation; 2009 Sep; 120(11 Suppl):S247-54. PubMed ID: 19752375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic fibroblast growth factor increased regional myocardial blood flow and limited infarct size of acutely infarcted myocardium in dogs.
    Miyataka M; Ishikawa K; Katori R
    Angiology; 1998 May; 49(5):381-90. PubMed ID: 9591530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic fibroblast growth factor increases regional myocardial blood flow and salvages myocardium in the infarct border zone in a rabbit model of acute myocardial infarction.
    Hasegawa T; Kimura A; Miyataka M; Inagaki M; Ishikawa K
    Angiology; 1999 Jun; 50(6):487-95. PubMed ID: 10378825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy.
    Gleeson BM; Martin K; Ali MT; Kumar AH; Pillai MG; Kumar SP; O'Sullivan JF; Whelan D; Stocca A; Khider W; Barry FP; O'Brien T; Caplice NM
    Stem Cells; 2015 Sep; 33(9):2726-37. PubMed ID: 25969127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paracrine role for mesenchymal stem cells in acute myocardial infarction.
    Li Z; Guo J; Chang Q; Zhang A
    Biol Pharm Bull; 2009 Aug; 32(8):1343-6. PubMed ID: 19652371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of MicroRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction.
    Huang F; Li ML; Fang ZF; Hu XQ; Liu QM; Liu ZJ; Tang L; Zhao YS; Zhou SH
    Cardiology; 2013; 125(1):18-30. PubMed ID: 23615185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
    Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.